<DOC>
	<DOCNO>NCT02073591</DOCNO>
	<brief_summary>This prospective , open label , single arm , observational multicenter study assess correlation PEST SCORAD score management AD Ceradan® regimen .</brief_summary>
	<brief_title>Correlation Study Between PEST SCORAD Management Atopic Dermatitis With Ceradan® Regimen</brief_title>
	<detailed_description>All eligible patient shall apply permitted topical steroid ( ) accord standard local practice For entire study period , patient apply Ceradan Cream® liberally twice daily , require use non-soap base wash twice daily . At screen visit , patient receive diary card ask track atopic dermatitis symptom 12 week . Retrospective information topical treatment use collected baseline .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Male female child age ≥6 month ≤6 year Baseline PEST score 3 4 Diagnosis mild moderate atopic dermatitis , grade 3 to11 , per NESS Diagnosis current flare ( increased dryness , itching , redness , swell general irritability ) baseline visit accord Investigator 's judgement Patients visited dermatologist ( dermatologistnaïve ) Agree participate provide write consent parent guardian ( assent applicable ) History severe episode atopic dermatitis ( example : oozing , crust ) Clinical sign skin infection ( viral , bacterial fungal ) Grading &gt; 11 define Nottingham Eczema Severity Score ( NESS ) within 3 month prior study inclusion Known reaction allergy test drug excipients steroids History cutaneous systemic viral ( include HIV AIDS ) , cutaneous mycotic cutaneous bacterial disease require topical systemic therapy study period Patients receive investigational drug take part clinical study investigational drug within three month prior start study treatment The patient expose therapy within set timeframe : . Systemic administration corticosteroid four week ; ii . Systemic administration immunosuppressive drug four week ; iii . UV therapy four week Any serious medical condition , opinion investigator , may interfere evaluation result Parents/guardians may unable complete patient diary questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Children</keyword>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>Ceradan</keyword>
	<keyword>PEST</keyword>
	<keyword>SCORAD</keyword>
</DOC>